ResearcherBeijing University of Chinese MedicineActive in the last 2 years

Cen Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-6198-8120; OpenAlex author ID A5053180405. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper

Papers 1

Harmine suppresses pancreatic cancer through DYRK1A-mediated hyper-activated RAS/MAPK inhibition. Co-author DOI 10.1016/j.bcp.2025.117291 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xia Li · 1 shared paper, 2025 · strength 0.27
- Paper Harmine suppresses pancreatic cancer through DYRK1A-mediated hyper-activated RAS/MAPK inhibition. DOI 10.1016/j.bcp.2025.117291 ↗
Yonggang Liu · 1 shared paper, 2025 · strength 0.27
- Paper Harmine suppresses pancreatic cancer through DYRK1A-mediated hyper-activated RAS/MAPK inhibition. DOI 10.1016/j.bcp.2025.117291 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.